Pharmacotherapeutic estimation of chronic gastritis in conditions of real clinical practice
DOI:
https://doi.org/10.24959/cphj.15.1341Keywords:
chronic gastritis, clinical and economic analysis, ABC-analysis, VEN-analysis, frequency analysis, formulary systemAbstract
Clinical and economic analysis of pharmacotherapy in patients with chronic gastritis (CG) in a particular healthcare institution (HCI) of Kharkov has been carried out. As many as 105 history cases of patients with CG aged from 35 to 59 years have been analyzed. The research lasted 6 months in 2013. Using the “formal” VEN-analysis it has been determined that the large majority of medicines (87.23%) prescribed to the patients with CG in the given HCI of Kharkov is presented in the State Formulary of Ukraine (SFU). Based on the results of the frequency analysis it has been found that the medicines mentioned are the most part of prescription medicines (91.15 %). Using the ABC-analysis it has been determined that the major part of costs (86.00 %) connected with pharmacotherapy of patients with CG are spent on them. The approaches for optimization of pharmacotherapy of CG in the given HCI of Kharkov and funds to carry them out have been proposed. In general, the pharmacotherapy prescribed can be considered as rational both from the clinical and economic points of view. Using indicators of the formulary system monitoring the estimation of its introduction level in the given HCI of Kharkov is given. The number of the medicines prescribed from the SFU compared to the total number of prescriptions (the indicator of the process) was 87.23%, and the number of the medicines prescribed for 1 patient (the indicator of the result) was 7.7. The results obtained show both an insufficient level of the formulary system introduction in this HCI and the urgency of further correction of pharmacotherapy of the patients with CG according to the SFU, as well as rationalization of the medicines prescribed for each individual patient.
References
Державний формуляр лікарських засобів України (п'ятий випуск, 2013 р.). – Режим доступу: http://www.dec.gov.ua.
Морозов А. М., Яковлєва Л. В., Бездітко Н. В. та ін. Оцінка клінічної та економічної доцільності використання лікарських засобів у лікувально-профілактичному закладі (супровід формулярної системи): Метод. рекоменд. – Х.: Стиль-Издат, 2013. – 36 с.
Наказ МОЗ України № 918 від 28.10.2010 р. «Про затвердження методичних рекоме-ндацій щодо моніторингу та оцінки дієвості формулярної системи на етапі її впрова-дження». – Режим доступу: http://www.dec.gov.ua.
Пошукова система «Стандарти надання медичної допомоги в Україні». – Режим дос-тупу: http: // www.medstandart.net.
Програмний комплекс «Аптека» компанії «Моріон». – Режим доступу: http://pharmbase.com.ua/poisk/.
Akhelova S. // Medical and Health Science Journal. – 2011. – Vol.8. - Р. 111-114.
Camila Alves Areda, Roni Cléber Bonizio, Osvaldo de Freitas. // Brazilian Journal of Pharmaceutical Sciences. – 2011. - Vol. 47, N 2. - Р.231-240.
Esposito D., Migliaccio-Walle K., Molsen E. Reliability and Validity of Data Sources for Outcomes Research & Disease and Health Management Programs. – Lawrenceville, NJ: ISPOR, 2013. – 467 р.
Gupta R., Gupta K., Jain Maj B. et al. // MJAFI. – 2007. – Vol. 63, N 4. – p. 325-327.
Kulkarni U., Dalvi K., Moghe V.V. еt al. // African Journal of Pharmacy and Pharmacology. – 2009. – Vol. 3, N 8. – P. 362-367.
Miller P. An Introduction to Health Economic Evaluation. The NIHR RDS for the East Midlands. – Yorkshire & the Humber, 2009. – 42 р.
Musaraj А., Musaraj А., Dervishi А. // Alexandria Journal of Medicine. – 2014. –Vol.,50, Issue 1. – P. 1–6.
Understanding Health Outcomes and Pharmacoeconomics / edited by MacKinnon E. – Jo-nes & Bartlett Publishers, 2011. – 218 р.
Wandalkar P., Pandit P. T., Zite A. R. // Indian Journal of Basic and Applied Medical Re-search. – 2013. - Vol.3,Issue-1. - P.126-131.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
